Telephone:+86 510 66901819

Current position:Home>>About us>>About us
Current position:About us

       Founded in 2014, Wuxi Tmaxtree Biotechnology Co., Ltd. , incubated by Wuxi Research Institute of Applied Technology, Tsing Hua University, has developed a novel plasma mutation breeding technology to obtain stable high-yielding good strains, which has enable it to become world’s pioneer of biological mutagenesis technology.    


        Based on the technology, Tmaxtree has developed the world’s first atmospheric and room temperature plasma (ARTP) mutation device, which can greatly reduce the cost of screening good strains. The device possesses features of Non-GMO and strong effect in mutation breeding with wide range of application in the field of prokaryotes (bacteria, actinomycetes) and eucaryon(mycete, yeast, algae, macrofungi).


         Based on the technology, Tmaxtree has developed the world’s first atmospheric and room temperature plasma (ARTP) mutation device, which can greatly reduce the cost of screening good strains. The device possesses features of Non-GMO and strong effect in mutation breeding with wide range of application in the field of prokaryotes (bacteria, actinomycetes) and eucaryon(mycete, yeast, algae, macrofungi).

Up to now, the ARTP mutation device has won the Gold Award of Geneva International Exhibition of Inventions, Thailand Award for Best International Invention and other awards from home and abroad. 
The Tmaxtree family includes a professional team of scientific researchers and intellectual elite from various fields. 


         Under the technological guidance of Professor Xin-hui Xing, who has experience over 20 years in bio-chemistry, with a passion for transferring technology to commercial application, Tmaxtree keeps on marching towards the leading position in this industry. In the near future, It expects that Tmaxtree will develop new and high throughput screening technology for more strains in bio-breeding industriy.


20170829223443_82040